MONDAY, Jan. 10, 2022 (HealthDay News) — For people newly diagnosed with advanced melanoma, a combination of two immunotherapy drugs can double the amount of time their cancer remains progression-free, a clinical trial has found. The treatment combines two drugs known as immune checkpoint inhibitors. One, called nivolumab (Opdivo), isContinue Reading

SUNDAY, Jan. 9, 2022 (HealthDay News) — Thyroid cancer diagnoses have spiked for U.S. women this past decade. That’s why it’s essential to pay attention to this small gland at the base of your neck. The thyroid is an important part of your endocrine system, producing a hormone that helpsContinue Reading

TUESDAY, Jan. 4, 2022 (HealthDay News) — Many insured cancer patients still experience serious money problems linked to their illness, new research affirms. For example, nearly 3 out of 4 insured patients with colon cancer have major financial hardship in the year after their diagnosis, which affects their social functioningContinue Reading